Levi & Korsinsky Notifies Investors With Losses on Their Investment in Keryx Biopharmaceuticals, Inc. of Class Action Lawsuit

Levi & Korsinsky Notifies Investors With Losses on Their Investment in Keryx
Biopharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of April 2,
2013 to Seek a Lead Plaintiff Position -- KERX

NEW YORK, Feb. 5, 2013 (GLOBE NEWSWIRE) -- Levi & Korsinsky announces that a
class action lawsuit has been commenced in the United States District Court
for the Southern District of New York on behalf of investors who purchased
Keryx Biopharmaceuticals, Inc. ("Keryx" or the "Company") (Nasdaq:KERX) stock
between June 1, 2009 and April 1, 2012.

For more information, click here:
http://zlk.9nl.com/keryx-biopharmaceuticals-kerx/.

The complaint alleges that the Company issued materially false and misleading
statements concerning the timing and success of its perifosine X-PECT Phase 3
Clinical Trial. As a result of these alleged misstatements, Keryx stock traded
at artificially inflated prices. On April 2, 2012, Keryx disclosed that its
Phase 3 Clinical Trial did not meet the primary endpoint of improving overall
patient survival versus the drug Capecitabine and a placebo. Shares of Keryx
fell from a close of $4.98 per share on March 30, 2012, to a close of $1.74
per share the following business day.

If you suffered a loss in Keryx you have until April 2, 2013to request that
the Court appoint you as lead plaintiff.Your ability to share in any recovery
doesn't require that you serve as a lead plaintiff. To obtain additional
information, contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or
by telephone at (877) 363-5972, or visit
http://zlk.9nl.com/keryx-biopharmaceuticals-kerx/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, and
Washington D.C. The firm has extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors throughout the
nation in securities and shareholder lawsuits. Attorney advertising. Prior
results do not guarantee similar outcomes.

CONTACT: Levi & Korsinsky, LLP
         Joseph Levi, Esq.
         Eduard Korsinsky, Esq.
         30 Broad Street - 24th Floor
         New York, NY 10004
         Tel: (212) 363-7500
         Toll Free:  (877) 363-5972
         Fax: (866) 367-6510
         www.zlk.com
 
Press spacebar to pause and continue. Press esc to stop.